HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shizuko Tanaka Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

1/2007The role of activating protein 1 in the transcriptional regulation of the human FCGR2B promoter mediated by the -343 G -> C polymorphism associated with systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shizuko Tanaka Research Topics

Disease

1Hodgkin Disease (Hodgkin's Disease)
01/2023
1Inflammation (Inflammations)
04/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2007
1Osteosarcoma (Osteogenic Sarcoma)
03/2006
1Autoimmune Diseases (Autoimmune Disease)
07/2005

Drug/Important Bio-Agent (IBA)

1Triglycerides (Triacylglycerol)IBA
01/2023
1Interleukin-33IBA
04/2011
1Interleukin-1 (Interleukin 1)IBA
04/2011
1CytokinesIBA
04/2011
1Interleukin-1 Receptor Accessory ProteinIBA
04/2011
1Proteins (Proteins, Gene)FDA Link
01/2007
1DNA (Deoxyribonucleic Acid)IBA
03/2006
1ElementsIBA
03/2006
1IgG Receptors (Fc gamma RI)IBA
07/2005

Therapy/Procedure

1Therapeutics
01/2023